[Expression of CERS2 in invasive breast cancer tissues and its clinical significance].
fshfly@126.com
Yan-yan
YY
Wang
Li-yong
LY
Gao
Yue-hua
YH
Zhao
Jin-yun
JY
Li
Qin
Q
Luo
Shao-hua
SH
Fan
D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D018275:Carcinoma, Lobular / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008207:Lymphatic Metastasis; D061986:MCF-7 Cells / Q000378:metabolism; D015411:Mastectomy, Modified Radical; D008565:Membrane Proteins / Q000378:metabolism*; D008875:Middle Aged; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D051049:Sphingosine N-Acyltransferase / Q000378:metabolism*; D015996:Survival Rate; D025521:Tumor Suppressor Proteins / Q000378:metabolism*
D008565:Membrane Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D051049:Sphingosine N-Acyltransferase; D025521:Tumor Suppressor Proteins; C438311:CERS2 protein, human; C508053:ERBB2 protein, human